Vaccination with nanoparticles combined with micro-adjuvants protects against cancer
Abstract Background Induction of strong T cell responses, in particular cytotoxic T cells, is a key for the generation of efficacious therapeutic cancer vaccines which yet, remains a major challenge for the vaccine developing world. Here we demonstrate that it is possible to harness the physiologica...
Main Authors: | Mona O. Mohsen, Matthew D. Heath, Gustavo Cabral-Miranda, Cyrill Lipp, Andris Zeltins, Marcos Sande, Jens V. Stein, Carsten Riether, Elisa Roesti, Lisha Zha, Paul Engeroff, Aadil El-Turabi, Thomas M. Kundig, Monique Vogel, Murray A. Skinner, Daniel E. Speiser, Alexander Knuth, Matthias F. Kramer, Martin F. Bachmann |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2019-04-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40425-019-0587-z |
Similar Items
-
Virus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax
by: Gustavo Cabral-Miranda, et al.
Published: (2017-05-01) -
Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles
by: Lisha Zha, et al.
Published: (2021-04-01) -
Shaping Modern Vaccines: Adjuvant Systems Using MicroCrystalline Tyrosine (MCT®)
by: Matthew D. Heath, et al.
Published: (2020-11-01) -
Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice
by: Zhang Quanfu, et al.
Published: (2011-06-01) -
Modular vaccine platform based on the norovirus-like particle
by: Vili Lampinen, et al.
Published: (2021-01-01)